Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 367 of 1,261
  1. US 10913761

    2,7-dibromospiro[fluorene-9,4′-piperidine] compounds

    Vertex Pharmaceuticals Incorporated · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  2. US 10913740

    JAK kinase inhibitor compounds for treatment of respiratory disease

    Theravance Biopharma R&D IP, LLC · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  3. US 10913750

    Tubulin-binding compounds, compositions and uses related thereto

    The Regents of the University of California · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  4. US 10913726

    Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them

    The Regents of the University of California · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  5. US 10913711

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  6. US 10913722

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  7. US 10912846

    Molecular probes for chemiluminescence imaging and in vivo detection of target molecules

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  8. US 10912834

    Topical formulations based on ionic species for skin treatment

    The Regents of the University of California · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  9. US 10912792

    Compounds and methods for modulating angiotensinogen expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  10. US 10912931

    Drug releasing coatings for balloon catheters

    Lutonix, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  11. US 10912932

    Drug releasing coatings for balloon catheters

    Lutonix, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  12. CA 3147876

    DERIVES DE LA 1,2,4-OXADIAZOL-5-ONE POUR LE TRAITEMENT DU CANCER

    BASILEA PHARM INT AG [CH] · Granted Feb 4, 2021 · Expires Jan 30, 2041

    granted
  13. US 10905769

    Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  14. US 10906914

    Furoquinolinediones as inhibitors of TDP2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  15. US 10906928

    Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

    Atea Pharmaceuticals, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  16. US 10905710

    Particles with RNA cleaving nucleobase polymers and uses for managing inflammatory disorders

    United States Government as represented by the Department of Veterans Affairs · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  17. US 10906940

    Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  18. US 10905666

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  19. US 10907175

    Isolated human cell with an inactivated glucocorticoid receptor gene

    Sangamo Therapeutics, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  20. US 10906898

    Cocrystal

    Takeda Pharmaceutical Company Limited · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  21. US 10905752

    VEGFR-2 targeting DNA vaccine for combination therapy

    Vaximm AG · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  22. US 10907151

    Compositions and methods for treating or preventing lupus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  23. US 10907124

    Biomimetic membranes, methods of manufacture and uses thereof

    The Regents of the University of California · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  24. US 10906916

    Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

    Valo Early Discovery, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.